Bernd R. Seizinger - 05 Feb 2024 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role
Director
Signature
/s/ Bernd R. Seizinger
Issuer symbol
APTOF
Transactions as of
05 Feb 2024
Net transactions value
$0
Form type
4
Filing time
07 Feb 2024, 16:56:08 UTC
Previous filing
25 Sep 2023
Next filing
14 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Director Stock Option (Right to Buy) Award $0 +3,333 $0.000000 3,333 05 Feb 2024 Common Shares 3,333 $2.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 50% on February 5, 2025; 25% on February 5, 2026; and 25% on February 5, 2027.